Sec Form 13D Filing - AISLING CAPITAL III LP filing for ASENSUS SURGICAL INC (ASXC) - 2018-06-05

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
SCHEDULE 13D/A
 
Under the Securities Exchange Act of 1934
(Amendment No. 6)*


 
TransEnterix, Inc.
(Name of Issuer)
 
Common Stock, $0.001 par value per share
(Title of Class of Securities)
 
89366M102
(CUSIP Number)
 
Aisling Capital
888 Seventh Avenue, 12th Floor
New York, NY 10106
(212) 651-6380
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
June 1, 2018
(Date of Event Which Requires Filing of This Statement)
 

 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
 
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 2 of 11
 
 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Aisling Capital III, LP
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
6,389,352
8
SHARED VOTING POWER
 
-0-
9
SOLE DISPOSITIVE POWER
 
6,389,352
10
SHARED DISPOSITIVE POWER
 
-0-
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
6,389,352
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
3.1% (1)
 
14
TYPE OF REPORTING PERSON
 
PN
 
 

(1)
All calculations of the percentages herein are based on an aggregate of 203,976,789 shares of Common Stock issued and outstanding as of May 4, 2018, as reported in the Issuers Quarterly Report on Form 10-Q filed with the Securities Exchange Commission (the SEC) on May 8, 2018.
 

CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 3 of 11

 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Aisling Capital Partners III, LP
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
6,389,352
8
SHARED VOTING POWER
 
-0-
9
SOLE DISPOSITIVE POWER
 
6,389,352
10
SHARED DISPOSITIVE POWER
 
-0-
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
6,389,352
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
3.1%
 
14
TYPE OF REPORTING PERSON
 
PN
 
 

CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 4 of 11

 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Aisling Capital Partners III LLC
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
6,389,352
8
SHARED VOTING POWER
 
-0-
9
SOLE DISPOSITIVE POWER
 
6,389,352
10
SHARED DISPOSITIVE POWER
 
-0-
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
6,389,352
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
3.1%
 
14
TYPE OF REPORTING PERSON
 
OO
 
 

CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 5 of 11

  
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Steve Elms
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
11,990
8
SHARED VOTING POWER
 
6,389,352
9
SOLE DISPOSITIVE POWER
 
11,990
10
SHARED DISPOSITIVE POWER
 
6,389,352
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
6,389,352
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
3.1%
 
14
TYPE OF REPORTING PERSON
 
IN
 
 

CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 6 of 11

 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Dennis Purcell
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
22,698
8
SHARED VOTING POWER
 
6,389,352
9
SOLE DISPOSITIVE POWER
 
22,698
10
SHARED DISPOSITIVE POWER
 
6,389,352
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
6,389,352
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
3.1%
 
14
TYPE OF REPORTING PERSON
 
IN
 
 

CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 7 of 11

  
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Andrew Schiff
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
5,755
8
SHARED VOTING POWER
 
6,389,352
9
SOLE DISPOSITIVE POWER
 
5,755
10
SHARED DISPOSITIVE POWER
 
6,389,352
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
6,389,352
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
3.1%
 
14
TYPE OF REPORTING PERSON
 
IN
 
 

CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 8 of 11
 
 
Item 1.
Security and Issuer.
 
This Amendment No. 6 to Schedule 13D (this Statement) amends and supplements the Schedule 13D as previously filed by the undersigned Reporting Persons (as defined below) on September 13, 2013, and amended by Amendment No. 1 to the Schedule 13D, filed by the Reporting Persons on December 10, 2013, Amendment No. 2 to the Schedule 13D, filed by the Reporting Persons on April 23, 2014, Amendment No. 3 to the Schedule 13D, filed by the Reporting Persons on February 5, 2016, Amendment No. 4 to the Schedule 13D filed by the Reporting Persons on May 9, 2017 and Amendment No. 5 to the Schedule 13D filed by the Reporting Persons on November 21, 2017, with respect to the Common Stock, $0.001 par value (the Common Stock), of TransEnterix, Inc. (f/k/a SafeStitch Medical, Inc. and Cellular Technical Services Company, Inc.), a Delaware corporation (the Issuer). The principal executive office of the Issuer is located at 635 Davis Drive, Suite 300, Durham, North Carolina 27713.
 
This Amendment No. 6 is being filed to report that, as of immediately following the distributions described in Item 5 below, the Reporting Persons ceased to beneficially own more than 5% of the Common Stock of the Issuer.
Item 2.
Identity and Background.

No material change.

Item 3.
Source and Amount of Funds or Other Consideration.
 
Item 3 is hereby amended and supplemented as follows:
 
On April 19, 2018, Aisling exercised the Series B Warrants at an exercise price of $1.00 and received 1,500,000 shares of Common Stock. The source of the exercise price paid for the shares was capital contributions from the partners of Aisling. No borrowed funds were used by Aisling in connection with the exercise of the Series B Warrants.


CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 9 of 11

 
 
Item 4.
Purpose of Transaction.

No material change.
 
Item 5.
Interest in Securities of the Issuer.
 
Items 5(a), (b) and (c) are amended and restated in their entirety as follows:
 
(a),(b) The aggregate percentage of shares of Common Stock reported as owned by each Reporting Person is based on 203,976,789 shares of Common Stock issued and outstanding as of May 4, 2018, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities Exchange Commission (the “SEC”) on May 8, 2018.
 
Reporting Person
Sole Voting/
Dispositive Power
Shared Voting/
Dispositive Power
Total Shares
% Ownership
Aisling Capital III, LP
6,389,352
0
6,389,352
3.1
Aisling Capital Partners III, LP
6,389,352
0
6,389,352
3.1
Aisling Capital Partners III LLC
6,389,352
0
6,389,352
3.1
Steve Elms
11,990
6,389,352
6,401,342
3.1
Dennis Purcell
22,698
6,389,352
6,412,050
3.1
Andrew Schiff
5,755
6,389,352
6,395,107
3.1
 
On June 1, 2018, Aisling distributed (the “Distribution”) 5,000,000 shares of Common Stock on a pro rata basis to its partners and members for no consideration. In the Distribution, Aisling Partners received 28,687 shares of Common Stock and Aisling Partners GP received 100 shares of Common Stock. Certain partners of Aisling, including Aisling Partners and Aisling Partners GP, made subsequent pro rata distributions (the “Subsequent Distribution”) of shares received to their respective partners or members for no consideration. In the Subsequent Distribution, Aisling Partners distributed all of the shares of Common Stock it received in the Distribution and Aisling Partners GP distributed all of the shares of Common Stock it received in the Distribution to their respective partners or members. The Distribution by Aisling to Aisling GP and Aisling Partners GP and the Subsequent Distribution by Aisling GP to Messrs. Elms, Purcell and Schiff did not result in a change in those parties' pecuniary interests in those shares of Common Stock.
 
As part of the Distribution and Subsequent Distribution, the following Reporting Persons received shares of Common Stock in the amounts set forth below:

Reporting Person
Number of Shares of
Common Stock
Distributed
Total Shares
Steve Elms
9,587
11,990
Steven A. Elms 2006 Trust
2,403
 
Dennis Purcell
20,342
22,698
Purcell Family 2006 Trust
2,356
 
Andrew Schiff
5,323
5,755
ANS 2006 Children’s Trust
432
 
(c) As described in Item 3, on April 19, 2018, Aisling exercised the Series B Warrants at an exercise price of $1.00 per share and received 1,500,000 shares of Common Stock.
 

CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 10 of 11
 
 
Item 6.
Contract, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
 
No material change.
 
Item 7.
Material to Be Filed as Exhibits.
 
The following documents are filed as exhibits hereto:
 
Exhibit 1:
 
 
   
Exhibit 2:
 
 
   
Exhibit 3:
 
 
   
Exhibit 4:
 
 
 

CUSIP No. 89366M102
 
SCHEDULE 13D/A
Page 11 of 11

 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Date: June 5, 2018
AISLING CAPITAL III, LP
 
     
By:
Aisling Capital Partners III, LP
 
 
General Partner
 
     
By:
Aisling Capital Partners III LLC
 
 
General Partner
 
     
By:
/s/ Dennis Purcell
 
 
Name: Dennis Purcell
 
 
Title: Managing Member
 
     
     
AISLING CAPITAL PARTNERS III, LP
 
     
By:
Aisling Capital Partners III LLC
 
 
General Partner
 
     
     
By:
/s/ Dennis Purcell
 
 
Name: Dennis Purcell
 
 
Title: Managing Member
 
     
     
AISLING CAPITAL PARTNERS III LLC
 
     
     
By:
/s/ Dennis Purcell
 
 
Name: Dennis Purcell
 
 
Title: Managing Member
 
     
     
By:
/s/ Steve Elms
 
 
Steve Elms
 
     
     
By:
/s/ Dennis Purcell
 
 
Dennis Purcell
 
     
     
By:
/s/ Andrew Schiff
 
 
Andrew Schiff